Hidden in Plain Sight: “Euglycemic Diabetes” as the Earliest Signal of Cardiometabolic Disease

Hidden in Plain Sight: “Euglycemic Diabetes” as the Earliest Signal of Cardiometabolic Disease

Hidden in Plain Sight: “Euglycemic Diabetes” as the Earliest Signal of Cardiometabolic DiseaseDr. John Sciales
Published on: 15/04/2026

Normal glucose doesn’t mean normal metabolism. Hidden insulin resistance and excess insulin drive inflammation and plaque formation, silently leading to heart disease long before standard labs show abnormalities.

Functional Wellness
Looking at the Heart to Guide Treatment: Why Imaging Must Come Before Medication

Looking at the Heart to Guide Treatment: Why Imaging Must Come Before Medication

Looking at the Heart to Guide Treatment: Why Imaging Must Come Before MedicationDr. John Sciales
Published on: 13/04/2026

Numbers estimate risk. Imaging reveals reality. True cardiovascular care begins when we stop guessing from labs and start seeing the disease directly—because what matters is not the number, but what’s happening inside your arteries.

Functional Wellness
The Bridge Between Sugar and Heart Disease: What Most People—and Most Doctors—Are Missing

The Bridge Between Sugar and Heart Disease: What Most People—and Most Doctors—Are Missing

The Bridge Between Sugar and Heart Disease: What Most People—and Most Doctors—Are MissingDr. John Sciales
Published on: 10/04/2026

Heart disease and diabetes are not separate, both stem from insulin resistance. Long before sugar rises, inflammation and vascular damage begin. “Normal” labs can miss it. Early metabolic testing and imaging reveal hidden disease and allow prevention at the root.

Functional Wellness
The Samurai Sword of Vascular Health How Nattokinase Cuts Through Fibrin, Inflammation, and Cardiometabolic Risk

The Samurai Sword of Vascular Health How Nattokinase Cuts Through Fibrin, Inflammation, and Cardiometabolic Risk

The Samurai Sword of Vascular Health How Nattokinase Cuts Through Fibrin, Inflammation, and Cardiometabolic RiskDr. John Sciales
Published on: 07/03/2026

Nattokinase, a fibrin-degrading enzyme from fermented soy, may influence clot biology. But cardiovascular disease begins years earlier with metabolic dysfunction, inflammation, and plaque formation.

Functional Wellness